Clinical Trial Update: Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and efficacy of EPO-018B for treating anemia in participants with end-stage renal disease receiving maintenance hemodialys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• EPO-018B

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure, Anemia | Phase 2 | Status: UNKNOWN